CN104031005B - 一种噻萘普汀钠中间体的制备方法 - Google Patents
一种噻萘普汀钠中间体的制备方法 Download PDFInfo
- Publication number
- CN104031005B CN104031005B CN201410236730.1A CN201410236730A CN104031005B CN 104031005 B CN104031005 B CN 104031005B CN 201410236730 A CN201410236730 A CN 201410236730A CN 104031005 B CN104031005 B CN 104031005B
- Authority
- CN
- China
- Prior art keywords
- reaction
- preparation
- acid
- temperature control
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 13
- 238000000034 method Methods 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000005864 Sulphur Substances 0.000 claims abstract description 3
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 3
- 229940095102 methyl benzoate Drugs 0.000 claims abstract description 3
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 239000012043 crude product Substances 0.000 claims description 6
- 239000012452 mother liquor Substances 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000002425 crystallisation Methods 0.000 claims description 5
- 230000008025 crystallization Effects 0.000 claims description 5
- 238000010792 warming Methods 0.000 claims description 5
- 239000006227 byproduct Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 229920000137 polyphosphoric acid Polymers 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000007171 acid catalysis Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 238000005498 polishing Methods 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 238000010189 synthetic method Methods 0.000 abstract description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000002699 waste material Substances 0.000 description 5
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- JICJBGPOMZQUBB-UHFFFAOYSA-N 7-[(3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid Chemical compound O=S1(=O)N(C)C2=CC=CC=C2C(NCCCCCCC(O)=O)C2=CC=C(Cl)C=C21 JICJBGPOMZQUBB-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 210000001320 hippocampus Anatomy 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 230000001519 thymoleptic effect Effects 0.000 description 2
- 229960005138 tianeptine Drugs 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000003982 neuronal uptake Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- PANBYUAFMMOFOV-UHFFFAOYSA-N sodium;sulfuric acid Chemical compound [Na].OS(O)(=O)=O PANBYUAFMMOFOV-UHFFFAOYSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410236730.1A CN104031005B (zh) | 2014-05-30 | 2014-05-30 | 一种噻萘普汀钠中间体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410236730.1A CN104031005B (zh) | 2014-05-30 | 2014-05-30 | 一种噻萘普汀钠中间体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104031005A CN104031005A (zh) | 2014-09-10 |
CN104031005B true CN104031005B (zh) | 2016-04-27 |
Family
ID=51462026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410236730.1A Active CN104031005B (zh) | 2014-05-30 | 2014-05-30 | 一种噻萘普汀钠中间体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104031005B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105503774B (zh) * | 2015-12-31 | 2018-11-06 | 济南诚汇双达化工有限公司 | 一种噻萘普汀钠中间体的制备方法 |
CN110172045B (zh) * | 2019-06-05 | 2023-05-12 | 甘肃皓天医药科技有限责任公司 | 一种用于制备噻奈普汀钠的中间体的制备方法 |
CN114507192A (zh) * | 2022-02-15 | 2022-05-17 | 上海微巨实业有限公司 | 一种用于制备噻奈普汀钠的中间体的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5888542A (en) * | 1996-04-24 | 1999-03-30 | Adir Et Compagnie | Matrix tablet allowing the prolonged release of the sodium salt of tianeptine after administration by the oral route |
CN103037969A (zh) * | 2010-06-23 | 2013-04-10 | 约翰森·马瑟公开有限公司 | 络合物 |
-
2014
- 2014-05-30 CN CN201410236730.1A patent/CN104031005B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5888542A (en) * | 1996-04-24 | 1999-03-30 | Adir Et Compagnie | Matrix tablet allowing the prolonged release of the sodium salt of tianeptine after administration by the oral route |
CN103037969A (zh) * | 2010-06-23 | 2013-04-10 | 约翰森·马瑟公开有限公司 | 络合物 |
Non-Patent Citations (3)
Title |
---|
11-氨基-3-氯-6,11-二氢-5,5-二氧代-6-甲基-二苯并[c,f][1,2]硫氮杂的合成;曹爽 等;《精细化工中间体》;20100430;第40卷(第2期);26-29 * |
3-氯-6-甲基二苯并[c,f][1,2]硫氮杂卓-11(6H)-酮5,5-二氧化物的合成;孙亮 等;《精细化工中间体》;20090630;第39卷(第3期);34-36、55 * |
Synthesis of functionalized 2-(arylthio)benzoates by formal [3+3] cyclizations of 3-arylthio-1-silyloxy-1,3-butadienes with 3-silyloxy-2-en-1-ones and 1,3-diacylcyclopropanes;Inam Iqbal,等;《Tetrahedron》;20090703;第65卷(第36期);7562-7572 * |
Also Published As
Publication number | Publication date |
---|---|
CN104031005A (zh) | 2014-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104031005B (zh) | 一种噻萘普汀钠中间体的制备方法 | |
CN104693009B (zh) | 萘磺化产物直接碱熔联产1-萘酚和2-萘酚的方法 | |
CN106336388A (zh) | 苯并呋喃‑2‑(3h)‑酮的合成方法 | |
CN103435631B (zh) | I型硫酸氢氯吡格雷的制备方法 | |
CN107522631A (zh) | 一种盐酸土霉素的制备方法 | |
CN101717376A (zh) | 甲苯直接萃取提纯橡胶硫化促进剂mbt颗粒的方法 | |
CN103896754A (zh) | 一种清洁制备4-羟基-4’-氯二苯甲酮的方法 | |
CN104557969A (zh) | 一种硫酸氢氯吡格雷的生产工艺 | |
CN104030924B (zh) | 苯甲酸苄酯的回收精制方法 | |
CN101260089A (zh) | 橡胶硫化促进剂mbt的精制新方法 | |
CN106045813B (zh) | 球磨法制备乙醇钠的方法 | |
CN104557462B (zh) | 一种甘露醇的提取方法 | |
CN104086466A (zh) | 2-氯-4-甲砜基苯甲酸的制备方法 | |
CN107488129A (zh) | 一种从l‑缬氨酸复合物中提纯l‑缬氨酸的方法 | |
CN103833541A (zh) | 一种2-甲基-1,4-萘醌的新合成方法 | |
CN105503774A (zh) | 一种噻萘普汀钠中间体的制备方法 | |
CN101708830A (zh) | 一种萃余酸的净化方法 | |
CN204779430U (zh) | 一种邻/对甲苯磺酰胺的主要原料邻/对甲苯磺酰氯的提纯设备 | |
CN104529937A (zh) | 溶剂套用连续化纯化橡胶硫化促进剂m的方法 | |
CN103896814A (zh) | 一种磺化去氢松香酸的制备方法 | |
CN102503777B (zh) | 一种对氨基苯酚重氮化水解法制备对苯二酚的后处理方法 | |
CN102911187A (zh) | 一种头孢丙烯的回收方法 | |
CN103342661A (zh) | 一种高纯丁二腈的结晶提纯方法 | |
CN103396304B (zh) | 一种神经酸的化学合成方法 | |
CN105037127A (zh) | 一种酮基布洛芬的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Ge Zhengquan Inventor after: Hu Junfeng Inventor after: Wang Tingjian Inventor after: Yang Yanjun Inventor after: Liao Guozhi Inventor before: Ge Zhengquan Inventor before: Hu Junfeng Inventor before: Wang Tingjian Inventor before: Yang Yanjun |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160830 Address after: 253100 Shandong Dezhou Plain Economic Development Zone north two Ring Road West first northbound Shandong Yunjia Pharmaceutical Co. Ltd. Patentee after: SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO.,LTD. Address before: 2350 250101, Pioneer Road, hi tech Zone, Shandong, Ji'nan Patentee before: JINAN CHENGHUISHUANGDA CHEMICAL INDUSTRY Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of intermediate of thianapeptine sodium Effective date of registration: 20220616 Granted publication date: 20160427 Pledgee: Shandong Pingyuan Rural Commercial Bank Co.,Ltd. Pledgor: SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO.,LTD. Registration number: Y2022980007784 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230726 Granted publication date: 20160427 Pledgee: Shandong Pingyuan Rural Commercial Bank Co.,Ltd. Pledgor: SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO.,LTD. Registration number: Y2022980007784 |